The Vienna Prograf and Endothelial Progenitor Cell Study
Status:
Completed
Trial end date:
2009-05-01
Target enrollment:
Participant gender:
Summary
The aim of the study is to determine if the conversion from the immunosuppressive agent
cyclosporine to tacrolimus contributes to an improvement of the cardiovascular risk factors,
better kidney function and immune system.